What is Reyon Pharmaceutical Co Price-to-Operating-Cash-Flow?
As of today (2024-06-08), Reyon Pharmaceutical Co's share price is ₩13450.00.
Reyon Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩188.73. Hence, Reyon Pharmaceutical Co's Price-to-Operating-Cash-Flow Ratio for today is 71.26.
The historical rank and industry rank for Reyon Pharmaceutical Co's Price-to-Operating-Cash-Flow or its related term are showing as below:
XKRX:102460'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 12.7 Med: 34.93 Max: 243.52
Current: 71.27
During the past 13 years, Reyon Pharmaceutical Co's highest Price-to-Operating-Cash-Flow Ratio was 243.52. The lowest was 12.70. And the median was 34.93.
Reyon Pharmaceutical Co's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was ₩-62.05.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩188.73.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Reyon Pharmaceutical Co was -65.90% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 20.30% per year.
During the past 13 years, Reyon Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 34.10% per year. The lowest was -58.70% per year. And the median was 0.65% per year.
Reyon Pharmaceutical Co Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Reyon Pharmaceutical Co's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Reyon Pharmaceutical Co Price-to-Operating-Cash-Flow Chart
|
Reyon Pharmaceutical Co Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
- |
81.74 |
55.24 |
45.30 |
35.16 |
|
Reyon Pharmaceutical Co Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
32.39 |
25.35 |
24.00 |
35.16 |
80.80 |
Competitive Comparison of Reyon Pharmaceutical Co's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Reyon Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Reyon Pharmaceutical Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Reyon Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Reyon Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.
Reyon Pharmaceutical Co Price-to-Operating-Cash-Flow Calculation
Reyon Pharmaceutical Co's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 13450.00 | / | 188.733 |
| = | 71.26 |
Reyon Pharmaceutical Co's Share Price of today is ₩13450.00.
Reyon Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩188.73.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Reyon Pharmaceutical Co (XKRX:102460) Business Description
Traded in Other Exchanges
N/A
Address
416, Yeongdong-daero, 8th floor, Gangnam-gu, Seoul, KOR
Reyon Pharmaceutical Co Ltd is a Korea-based pharmaceutical company. It is engaged in the manufacturing and distribution of specialty medicines and raw materials. The main business of the company has been divided into generic drugs, original drugs, and drug substances The key products include eye drops, injection, antibiotics, skeletal muscle relaxants, coagulation drugs, anti-inflammatory enzymes, and blood vessels dialectic drugs, among others.
Reyon Pharmaceutical Co (XKRX:102460) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:102460 has been successfully added to your